VAL401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VAL401, covering 2018-10-15 to 2018-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer [Phase 2]